Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dentsply Sirona (XRAY) EBIAT (2016 - 2025)

Dentsply Sirona's EBIAT history spans 17 years, with the latest figure at -$146.0 million for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 66.05% year-over-year to -$146.0 million, compared with a TTM value of -$598.0 million through Dec 2025, up 34.36%, and an annual FY2025 reading of -$598.0 million, up 34.29% over the prior year.
  • EBIAT for Q4 2025 was -$146.0 million at Dentsply Sirona, up from -$427.0 million in the prior quarter.
  • The five-year high for EBIAT was $119.0 million in Q4 2021, with the low at -$1.1 billion in Q3 2022.
  • Average EBIAT over 5 years is -$109.2 million, with a median of $6.5 million recorded in 2024.
  • Year-over-year, EBIAT crashed 1382.14% in 2022 and then skyrocketed 546.67% in 2023.
  • Tracing XRAY's EBIAT over 5 years: stood at $119.0 million in 2021, then plummeted by 112.61% to -$15.0 million in 2022, then skyrocketed by 546.67% to $67.0 million in 2023, then tumbled by 741.79% to -$430.0 million in 2024, then surged by 66.05% to -$146.0 million in 2025.
  • Per Business Quant, the three most recent readings for XRAY's EBIAT are -$146.0 million (Q4 2025), -$427.0 million (Q3 2025), and -$44.0 million (Q2 2025).